L-701,324
| |
| Nazivi | |
|---|---|
| Preferisani IUPAC naziv
7-hloro-4-hidroksi-3-(3-fenoksifenil)-1H-hinolin-2-on | |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| ECHA InfoCard | 100.162.301 |
| EC broj | 634-309-2 |
| |
| Svojstva | |
| C21H14ClNO3 | |
| Molarna masa | 363,80 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
L-701,324 je antagonist NMDA receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Christina Zellinger; Josephine D Salvamoser; Jonna Soerensen; Erwin A van Vliet; Eleonora Aronica; Jan Gorter; Heidrun Potschka (2014). „Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model”. pilepsy Res. 108 (4): 634—43. doi:10.1016/j.eplepsyres.2014.02.012.
